The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: A systematic review and meta-analysis
Chronic Respiratory Disease · 2025
DOI: 10.1177/14799731251346194 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Chronic Respiratory Disease, 2025. Verfasst von Hassan Alrabbaie und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Rehabilitation Sciences, Faculty of Health Science, McMaster University, Hamilton, ON, Canada. Hauptthemen laut MEDLINE: Metabolic Syndrome, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Objective
Metabolic syndrome (MetS) is a cluster of factors that increase the risk of cardiovascular disease and type 2 diabetes. It is highly prevalent among patients with Chronic Obstructive Pulmonary Disease (COPD). This systematic review and meta-analysis assessed MetS prevalence in COPD patients, focusing on variations by gender, diagnostic criteria, and disease severity.
Methods
We systematically searched MEDLINE, Embase, Scopus, and CINAHL. Two reviewers independently extracted data using a standardized form, and study quality was assessed with the Joanna Briggs Institute checklist. Prevalence rates, with 95% confidence intervals (CI), were calculated using a random-effects model. Subgroup analyses by sex, COPD severity, and MetS components were conducted.
Results
Forty-two studies, including 54,278 COPD patients, were analyzed. Overall, the prevalence of MetS was 37% (95% CI: 30.6–43.8%; I 2 = 99.03%, p < 0.001). Prevalence was 48% (95% CI 38.1 to 57.5) in males and 43% (95% CI 38.3 to 48.8) in females. Among studies using the Alberti definition, the pooled prevalence was 46% (95% CI 35.6 to 56.3). Patients with GOLD stage II showed a prevalence of 44% (95% CI 37.3 to 50.4). The most common MetS components were Hypertension 58% (95% CI 47.2 to 68.0) and increased waist circumference 51% (95% CI 37.1 to 64.6).
Conclusion
MetS is highly prevalent among COPD patients. Standardized diagnostic criteria are needed, and early detection with integrated care is recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Rehabilitation Sciences, Faculty of Health Science, McMaster University, Hamilton, ON, Canada.
- Department of Rehabilitation Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan.
- Department of Respiratory Medicine, West Park Healthcare Centre, Toronto, Canada.
- Department of Physical Therapy, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
- Rehabilitation Sciences Institute, School of Graduate Studies, University of Toronto, Toronto, ON, Canada.
ORCID-Profile: Hassan Alrabbaie, Marla Beauchamp
Zitieren
APA
Alrabbaie, H., Al-Wardat, M., Etoom, M., Beauchamp, M., Goldstein, R., & Brooks, D. (2025). The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Chronic Respiratory Disease. https://doi.org/10.1177/14799731251346194
Vancouver
Alrabbaie H, Al-Wardat M, Etoom M, Beauchamp M, Goldstein R, Brooks D. The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Chronic Respiratory Disease. 2025. doi:10.1177/14799731251346194
BibTeX
@article{Alrabbaie2025,
author = {Alrabbaie, Hassan and Al-Wardat, Mohammad and Etoom, Mohammad and Beauchamp, Marla and Goldstein, Roger and Brooks, Dina},
title = {The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: A systematic review and meta-analysis},
journal = {Chronic Respiratory Disease},
year = {2025},
doi = {10.1177/14799731251346194}
}
EUVIMED